Federica Barutta (F Barutta)

Publication Activity (10 Years)

Years Active: 2016-2023
Publications (10 Years): 11

Top Topics

Diabetic Nephropathy

Angiotensin Converting Enzyme

Cardiovascular Disease

Top Venues

Acta diabetologica

Diabetes/metabolism research and reviews

This page only lists publications with an associated author ORCID identifier.

Publications

Stefania Bellini, Simonetta Guarrera, Giuseppe Matullo, Casper Schalkwijk, Coen D Stehouwer, Nish Chaturvedi, Sabita S Soedamah-Muthu, Federica Barutta, Gabriella Gruden
Serum MicroRNA-191-5p Levels in Vascular Complications of Type 1 Diabetes: the EURODIAB Prospective Complications Study. The Journal of clinical endocrinology and metabolism (2023)
Federica Barutta, Stefania Bellini, Marilena Durazzo, Gabriella Gruden
Novel Insight into the Mechanisms of the Bidirectional Relationship between Diabetes and Periodontitis. Biomedicines 10 (1) (2022)
Federica Barutta, Stefania Bellini, S Kimura, K Hase, B Corbetta, A Corbelli, F Fiordaliso, S Bruno, L Biancone, A Barreca, M G Papotti, Emilio Hirsch, Miriam Martini, R Gambino, M Durazzo, H Ohno, Gabriella Gruden
Protective effect of the tunneling nanotube-TNFAIP2/M-sec system on podocyte autophagy in diabetic nephropathy. Autophagy (2022)
Federica Barutta, Stefania Bellini, Gabriella Gruden
Mechanisms of podocyte injury and implications for diabetic nephropathy. Clinical science (London, England : 1979) 136 (7) (2022)
Federica Barutta, Beatrice Corbetta, Stefania Bellini, Simonetta Guarrera, Giuseppe Matullo, Michela Scandella, Casper Schalkwijk, Coen D Stehouwer, Nish Chaturvedi, Sabita S Soedamah-Muthu, Marilena Durazzo, Gabriella Gruden
MicroRNA 146a is associated with diabetic complications in type 1 diabetic patients from the EURODIAB PCS. Journal of translational medicine 19 (1) (2021)
Federica Barutta, Stefania Bellini, Silvia Canepa, Marilena Durazzo, Gabriella Gruden
Novel biomarkers of diabetic kidney disease: current status and potential clinical application. Acta diabetologica 58 (7) (2021)
Federica Barutta, Stefania Bellini, Beatrice Corbetta, Marilena Durazzo, Gabriella Gruden
The future of diabetic kidney disease management: what to expect from the experimental studies? Journal of nephrology 33 (6) (2020)
Federica Barutta, Sara Bernardi, Giuseppe Gargiulo, Marilena Durazzo, Gabriella Gruden
SGLT2 inhibition to address the unmet needs in diabetic nephropathy. Diabetes/metabolism research and reviews 35 (7) (2019)
Federica Barutta, S Bellini, Raffaella Mastrocola, G Bruno, G Gruden
MicroRNA and Microvascular Complications of Diabetes. International journal of endocrinology 2018 (2018)
Federica Barutta, Stefania Bellini, Raffaella Mastrocola, R Gambino, Fabiana Piscitelli, Vincenzo Di Marzo, Beatrice Corbetta, V Kiran Vemuri, Alexandros Makriyannis, Laura Annaratone, Graziella Bruno, Gabriella Gruden
Reversal of albuminuria by combined AM6545 and perindopril therapy in experimental diabetic nephropathy. British journal of pharmacology 175 (23) (2018)
Federica Barutta, Graziella Bruno, Giuseppe Matullo, Nish Chaturvedi, Serena Grimaldi, Casper Schalkwijk, Coen D Stehouwer, John H Fuller, Gabriella Gruden
MicroRNA-126 and micro-/macrovascular complications of type 1 diabetes in the EURODIAB Prospective Complications Study. Acta diabetologica 54 (2) (2016)